BioAtla (BCAB) Other Working Capital Changes (2021 - 2026)
BioAtla (BCAB) posted quarterly Other Working Capital Changes of $116000.0 for Q1 2026, up 514.29% year-over-year from $18883.7 in Q1 2025, and down 51.26% quarter-over-quarter from $238000.0 in Q4 2025.
BioAtla (BCAB) Other Working Capital Changes (2021 - 2026) Analysis & Trends
BioAtla's Other Working Capital Changes history runs 6 years deep, the most recent figure standing at $116000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 514.29% year-over-year to $116000.0; the TTM figure through Mar 2026 stood at $488000.0 (up 230.83% YoY), while the FY2025 annual figure was $344000.0, up 153.67% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $116000.0, down from $238000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $3.0 million in Q1 2025, with the low at -$2.6 million in Q2 2025.
- The 5-year median for Other Working Capital Changes is -$385000.0 (2023), against an average of -$68941.2.
- The sharpest annual moves came in 2025 and 2026: Other Working Capital Changes plunged 1144.44% in 2025, then soared 514.29% in 2026.
- BioAtla's Other Working Capital Changes stood at -$140000.0 in 2022, then retreated by 7.14% to -$150000.0 in 2023, then decreased by 9.33% to -$164000.0 in 2024, then surged by 245.12% to $238000.0 in 2025, then tumbled by 51.26% to $116000.0 in 2026.
- Business Quant data shows BCAB's Other Working Capital Changes at $116000.0 in Q1 2026, $238000.0 in Q4 2025, and $358000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | BioAtla | 5.28 Mn | 5.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6,000.00 |
| Jun 30, 2026 | -6,000.00 |
| Jun 30, 2026 | -6,000.00 |
| Mar 31, 2026 | 116,000.00 |
| Mar 31, 2026 | 116,000.00 |
| Mar 31, 2026 | 116,000.00 |
| Dec 31, 2025 | 238,000.00 |
| Dec 31, 2025 | 238,000.00 |
| Dec 31, 2025 | 238,000.00 |
| Sep 30, 2025 | 358,000.00 |
| Sep 30, 2025 | 358,000.00 |
| Sep 30, 2025 | 358,000.00 |
| Jun 30, 2025 | -224,000.00 |
| Jun 30, 2025 | -224,000.00 |
| Jun 30, 2025 | -224,000.00 |
| Mar 31, 2025 | -28,000.00 |
| Mar 31, 2025 | -28,000.00 |
| Mar 31, 2025 | -28,000.00 |
| Dec 31, 2024 | -164,000.00 |
| Dec 31, 2024 | -164,000.00 |